• Toremifene Citrate: From Binding to Biology

  2026-09-21

  Toremifene Citrate is an oral selective estrogen receptor modulator that connects receptor pharmacology with interpretable breast cancer research. This guide presents an assay-to-translation framework for studying estrogen receptor signaling, exposure, and hormone receptor modulation.

• DFCP1 Regulates Starvation-Driven ATGL Lipolysis

  2026-09-21

  The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of lipid droplet breakdown, showing that it recruits ATGL during starvation while limiting ATGL dissociation from droplets. This finding shifts attention from ATGL localization alone to the regulation of enzyme residence time as a determinant of lipolytic output.

• Stiripentol: A Practical LDH Inhibitor Workflow

  2026-09-20

  Stiripentol gives researchers a reversible way to interrogate LDH-dependent lactate flux in neuronal, metabolic, and immunometabolic models. This guide connects assay design, formulation, controls, and troubleshooting while separating established epilepsy-research evidence from exploratory tumor-microenvironment applications.

• From RNA Craft to TLS-Driven Cancer Immunity

  2026-09-19

  Mechanistic findings from a spleen-targeted neoantigen mRNA vaccine study show why RNA design, capping, tailing, translation, and delivery must be treated as one translational system. This article connects those insights with practical strategy for reproducible mRNA preparation using the HyperScribe™ All in One mRNA Synthesis Kit (ARCA, T7, poly(A)).

• Ruxolitinib: From JAK Selectivity to Assay Insight

  2026-09-18

  Ruxolitinib (INCB018424) is a selective JAK1/2 inhibitor with strong relevance to myelofibrosis and myeloproliferative disorder research. This article explains how to interpret its pathway and cellular effects using a cross-domain assay framework grounded in inflammatory biology.

• T7 RNA Polymerase: From Template to RNA Vaccine

  2026-09-18

  T7 RNA Polymerase enables promoter-defined RNA synthesis from linearized plasmids and PCR templates. This guide connects transcription design with downstream RNA vaccine and dendritic-cell assays, emphasizing template quality, RNA integrity, and interpretation of biological outcomes.

• AZD1480: JAK2 Inhibitor Workflows

  2026-09-17

  AZD1480 enables direct interrogation of tumor-intrinsic JAK2/STAT3 signaling, from phosphoprotein kinetics in myeloma cells to combination studies involving immune-mediated survival responses. This workflow-oriented guide covers formulation, assay design, translational model selection, and troubleshooting for using the compound as a research tool.

• nor-NOHA Acetate: Designing Metabolic Assays

  2026-09-17

  Explore how nor-NOHA acetate can dissect arginine partitioning, apoptosis induction in HepG2 cells, and endothelial function restoration. This article adds an assay-design framework linking reversible arginase inhibition to, but carefully distinguishing it from, CD36-driven immune escape in AML.

• Calpeptin: Practical Calpain Inhibitor Workflows

  2026-09-16

  Calpeptin combines nanomolar calpain 1 inhibition with a practical workflow for connecting protease activity to fibrosis, inflammation, and cell-death phenotypes. This guide covers dose finding, orthogonal readouts, sample handling, and troubleshooting for pulmonary fibrosis research.

• 5-Azacytidine Workflows for DNA Demethylation

  2026-09-16

  Build reproducible 5-Azacytidine assays for gene reactivation, leukemia cytotoxicity, and cancer-cell dormancy. This guide connects practical formulation and dosing choices with the AZA–retinoic acid strategy reported for suppressing metastatic outgrowth.

• Chronic Stress, Mitochondria, and Depression-Like Behavior

  2026-09-15

  A February 2025 rat study used chronic unpredictable mild stress and intracerebroventricular MnTBAP to connect mitochondrial dysfunction with neuroinflammation and depression-like behavior. Its main contribution is experimental support for mitochondria as a modifiable contributor to stress-related behavioral changes, while route, model validity, and antioxidant specificity limit direct clinical translation.

• PA-824: Reliable TB Assay Design

  2026-09-15

  This scenario-driven guide explains how PA-824, SKU A1736, can improve planning and interpretation of Mycobacterium tuberculosis viability and susceptibility experiments. It connects formulation, mechanistic evidence, assay controls, storage, and vendor documentation to more reproducible laboratory decisions.

• Cisplatin (CDDP) Workflows for Cancer Research

  2026-09-14

  Build more reproducible Cisplatin workflows for viability, apoptosis, DNA-damage, resistance, and xenograft studies. A recent enzyme-responsive delivery study shows how CDDP assays can be extended from single-agent cytotoxicity to mechanism-guided combination research.

• Calpeptin Workflows for EV and Fibrosis Research

  2026-09-14

  Calpeptin connects calpain biology with practical assays for extracellular-vesicle release, pulmonary fibrosis, and inflammatory signaling. This guide translates published EV findings into controlled workflows, normalization strategies, and troubleshooting decisions for reproducible cell-based research.

• APEX2 Enables TERT Expression in Human Stem Cells

  2026-09-13

  This preprint identifies APEX2, but not its paralog APEX1, as a contributor to efficient TERT expression and telomerase activity in human embryonic stem cells and a melanoma cell line. Its RNA-seq and chromatin-binding data suggest that APEX2 may connect DNA repair at repetitive elements with regulation of TERT transcription.

554 records 4/37 page Previous Next 12345 下5页 Last page